Sun Valley Research Center
Generated 5/4/2026
Executive Summary
Sun Valley Research Center is a privately-held contract research organization (CRO) founded in 1998 and based in Imperial, California. The company specializes in conducting clinical trials for biotech and pharmaceutical sponsors, with a strong focus on serving a rural, underserved, and predominantly Latino community. Its therapeutic expertise spans oncology, immunology, and neuroscience, including psychiatry. By emphasizing patient recruitment and trial execution in a region with limited access to clinical research, Sun Valley Research Center addresses a critical gap in healthcare equity. Its deep community ties and experience in diverse therapeutic areas position it as a valuable partner for sponsors seeking to improve trial diversity and reach underrepresented populations. As a private CRO with no disclosed funding or valuation, Sun Valley Research Center operates on a service-based revenue model, generating income through contracts with sponsors. The company's growth prospects are tied to the increasing demand for decentralized and community-based clinical trials, as well as regulatory emphasis on diversity in research. While it lacks the high-risk/high-reward profile of drug developers, its niche focus and established operations provide a stable foundation. Potential catalysts include securing new contracts with large pharmaceutical companies or expanding its service offerings. Overall, Sun Valley Research Center represents a steady, socially impactful business within the clinical trial ecosystem.
Upcoming Catalysts (preview)
- Q3 2026Award of new clinical trial contracts60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)